academia and industry

Drug Companies and NIH in $230 Million Joint Project for Alzheimer’s, Diabetes, Lupus and Arthritis

Drug Companies and NIH in $230 Million Joint Project for Alzheimer’s, Diabetes, Lupus and Arthritis

Along with funding from the United States government and ten large pharmaceutical companies, the National Institutes of Health (NIH), Bethesda, Maryland will split the cost of a new multimillion project targeting common chronic human diseases. The companies involved include Pfizer Inc., Eli Lilly & Co, AbbVie Inc., Biogen Idec Inc., Bristol-Myers Squibb Co., Glaxo Smith […]

Massachusetts Neuroscience Consortium: A Collaborative Model between Government, Academia and Industry

Massachusetts Neuroscience Consortium: A Collaborative Model between Government, Academia and Industry

Laboratories in academia and industry often work independently, but recently, a coalition of academic researchers, pharmaceutical companies and state governments announced the formation of the Massachusetts Neuroscience Consortium. The $1.75 million partnership intends to fundamentally shift the neurological disease research. Founders of this new project recognized that a highly collaborative and coordinated effort must be […]